Jeffrey Fisher
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: Oregon National Primate Research Center (2005); United States Food and Drug Administration (2020–2022); Center for Drug Evaluation and Research (2025); Emory University (2005); AID Atlanta (2005); Center for Psychobiology and Behavioral Medicine (2003); Emory National Primate Research Center (2003)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Jeffrey Fisher's research focuses on the application of physiologically based pharmacokinetic (PBPK) modeling to predict drug concentrations in various biological systems. He has investigated the pharmacokinetics of oseltamivir in pregnant rhesus macaques, aiming to inform clinical dosing across trimesters. Additionally, his work includes studying the pharmacokinetics of cannabidiol and its metabolites in rhesus monkeys and rabbits. Fisher also examines considerations for route-to-route extrapolation in assessing the safety of oral substance exposure. His scholarship includes 11 publications with 463 citations and an h-index of 7. He has collaborated with researchers including Frederick A. Beland and Gonçalo Gamboa da Costa at the National Center for Toxicological Research.
Metrics
- h-index: 7
- Publications: 11
- Citations: 467
Selected Publications
-
Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters (2025)
-
Considerations for Applying Route-to-Route Extrapolation to Assess the Safety of Oral Exposure to Substances (2022)
-
Creatinine‐Based Renal Function Assessment in Pediatric Drug Development: An Analysis Using Clinical Data for Renally Eliminated Drugs (2020)
-
Pharmacokinetics of oseltamivir phosphate and oseltamivir carboxylate in non-pregnant and pregnant rhesus monkeys (2020)
-
Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community (2017)
Collaboration Network
Top Collaborators
- Considerations for Applying Route-to-Route Extrapolation to Assess the Safety of Oral Exposure to Substances
- Considerations for Applying Route-to-Route Extrapolation to Assess the Safety of Oral Exposure to Substances
- Considerations for Applying Route-to-Route Extrapolation to Assess the Safety of Oral Exposure to Substances
- Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters
- Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters
- Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters
- Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters
- Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters
- Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters
Similar Researchers
Based on overlapping research topics